News
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
Health & Biotech
MGC Pharma strikes exclusive world-wide product distribution agreement
Health & Biotech
Weed Week: Legal pot is a thing in Canberra — could NSW follow suit?
Health & Biotech
MGC Pharmaceuticals launches new clinical study into brain cancer treatment
Health & Biotech
MGC Pharma makes strong debut as London Stock Exchange’s first medicinal cannabis company
Health & Biotech
MGC Pharma is to become the first medicinal cannabis company to list on the London Stock Exchange
Stockhead TV
V-Con: Medical cannabis – green grass, green growth
Health & Biotech
MGC Pharma is soon to be admitted to the London Stock Exchange
Health & Biotech
MGC Pharma attracts $5m grant for its Malta-based production facility
Health & Biotech
MGC Pharmaceuticals confirms Phase II trial success for anti-inflammatory COVID treatment
News
10 at 10: These ASX stocks have found their voice this morning
Health & Biotech
Here’s how pot execs think the UN’s big cannabis shift can affect pot stocks in Australia
News
Last Orders: What you might have missed on the ASX today
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
MGC Pharma expands network in Australia with clinics deal
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
MGC Pharma achieves success in brain cancer treatment trial
Health & Biotech